Last reviewed · How we verify
NCT05035888
Prophylactic Norepinephrine and Phenylephrine Boluses for Postspinal Anesthesia Hypotension
NA trial testing Phenylephrine in Adverse Effect in 80 participants. Completed in 3 January 2023.
3 January 2023
Quick facts
| Lead sponsor | General Hospital of Ningxia Medical University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 5 September 2022 |
| Primary completion | 3 January 2023 |
| Estimated completion | 3 January 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- Phenylephrine (phenylephrine) — full drug profile →
- Norepinephrine (NOREPINEPHRINE) — full drug profile →
Conditions studied
- Adverse Effect — all drugs for Adverse Effect →
Sponsor
General Hospital of Ningxia Medical University
Who can join
Adults 18 to 45, female only, with Adverse Effect. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to investigate the potency between prophylactic norepinephrine and phenylephrine boluses for postspinal anesthesia hypotension in patients undergoing caesarean section.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Prophylactic Norepinephrine and Phenylephrine Boluses to Prevent Postspinal Anesthesia Hypotension During Cesarean Section: A Randomized Sequential Allocation Dose-Finding Study.
Guo L, Xu X, Qin R, Shi Y, et al · · 2023 · cited 8× · PMID 37249928 · DOI 10.2147/dddt.s406671
Verify or expand the search:
- PubMed search for NCT05035888
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Phenylephrine
Trials testing the same drug.
- NCT06648850 — Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth · Phase 2, PHASE3 · not yet recruiting
- NCT06158035 — ED90 of Norepinephrine and Phenylephrine Boluses Under Intensive Treatment in Preeclamptic Patients · NA · unknown
- NCT07033845 — Pharmacokinetic Study of Topical Phenylephrine · EARLY_PHASE1 · recruiting
- NCT06158009 — ED90 of Norepinephrine and Phenylephrine Boluses Under Intensive Treatment · NA · unknown
- NCT06508359 — Norepinephrine and Phenylephrine for Spinal Anesthesia-induced Hypotension. · NA · not yet recruiting
Other recruiting trials for Adverse Effect
Currently open trials in the same condition.
- NCT06570629 — Addressing Unintentional Leakage When Using Nasal CPAP - Study B · NA · recruiting
- NCT06570616 — Addressing Unintentional Leakage When Using Nasal CPAP - Study A · NA · recruiting
- NCT06467045 — Frequency of Adverse Events in Pediatric Patients Receiving Sedation for Magnetic Resonance Imaging · recruiting
Other General Hospital of Ningxia Medical University trials
Trials by the same sponsor.
- NCT07496086 — External Oblique Intercostal Block Versus Transversus Abdominis Plane Combined With Rectus Sheath Block on Postoperative · NA · recruiting
- NCT07396545 — External Oblique Intercostal Block Versus Erector Spinae Plane Block on Postoperative Pain in Laparoscopic Radical Gastr · NA · recruiting
- NCT07366853 — Feasibility and Safety of Sciatic Nerve Paraneural Sheath Block Using a Mid-Femoral Lateral Approach · NA · not yet recruiting
- NCT07239531 — The Application of Intermittent Training in Clinical Skills Simulation Training · NA · not yet recruiting
- NCT07248683 — Application of Intermittent Training in Radial Artery Puncture and Catheterization Skills Under Ultrasound-Guided Line G · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05035888 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by General Hospital of Ningxia Medical University
- Last refreshed: 5 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05035888.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing